United Kingdom· GB-APID-34624011000001103
Varuby 90mg tablets
A rolapitant product containing rolapitant, registered in United Kingdom by Tesaro UK Ltd. The same ATC class is registered in 4 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Rolapitant is registered in 4 of 19 countries.
Countries holding a registration under ATC A04AD14 (rolapitant), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Rolapitant · ATC A04AD14
4 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Rolapitant
- Manufacturer
- Tesaro UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A04AD14
- ATC class
- Rolapitant
- Defined daily dose
- 0.18 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin0369656000018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
240 interactions on record for rolapitant.
Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rolapitant · interactions on record
240 records
- 26 severe
- 207 moderate
- 7 minor
Most severe, free to view
- EliglustatA16AX10severe
- EdoxabanB01AF03severe
- BetrixabanB01AF04severe
- BerotralstatB06AC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rolapitant in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/956d7689-12bf-40da-896c-53a4d85df515 GET /v1/drugs/956d7689-12bf-40da-896c-53a4d85df515?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34624011000001103",
"desc": "Varuby 90mg tablets (Tesaro UK Ltd)",
"form": "Oral tablet",
"vpid": "34625711000001102",
"source": "dmd",
"vtm_id": "777461006",
"strength": "90 mg",
"substance": "Rolapitant",
"ingredient": "Rolapitant hydrochloride monohydrate",
"supplier_code": "34539211000001101"
}See everything about rolapitant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.